The BeLimumab Antiphospholipid Syndrome Trial (BLAST)
Condition:   Antiphospholipid Syndrome Intervention:   Drug: Belimumab Sponsor:   University of Turin, Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 25, 2021 Category: Research Source Type: clinical trials